Oncology & Cancer
Final overall survival results of carboplatin + nab-paclitaxel ± atezolizumab in advanced squamous NSCLC
Patients with Stage IV squamous non-small cell lung cancer enrolled in clinical trial to test the immunotherapy atezolizumab and chemotherapy against chemotherapy alone experienced a longer survival rate, among a subgroup ...
Sep 10, 2019
0
0